Contact
Please use this form to send email to PR contact of this press release:
Opiant Pharmaceuticals Secures $50 Million in Convertible Debt Financing
TO:
Please use this form to send email to PR contact of this press release:
Opiant Pharmaceuticals Secures $50 Million in Convertible Debt Financing
TO: